RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwire - November 12, 2008) - Adherex Technologies Inc. (TSX: AHX)(AMEX: ADH), a biopharmaceutical company dedicated to solving problems for patients with cancer, today reported its financial results for the third quarter ended September 30, 2008. All amounts are in U.S. dollars.
